Table of Content

1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Market Definition
3.2. Key Drivers
3.2.1. Growing Prevalence Of Hypertension Across The Globe
3.2.2. Surge In Disposable Income And Healthcare Spending
3.2.3. Rising Aging Population
3.3. Key Restraints
3.3.1. Patent Expirations
3.3.2. Delay In Product Launches

4. Key Analytics
4.1. Porter’S Five Force Analysis
4.1.1. Threat Of New Entry
4.1.2. Threat Of Substitution
4.1.3. Buyer’S Power
4.1.4. Supplier’S Power
4.1.5. Competitive Rivalry
4.2. Regulatory Framework
4.3. Opportunity Matrix
4.4. Vendor Landscape
4.5. Key Investment Insights

5. Market By Drug Class
5.1. Calcium Channel Blockers
5.2. Ace Inhibitors
5.3. Beta-Adrenergic Blockers
5.4. Diuretics
5.5. Vasodilators
5.6. Other Drug Class

6. Market By End-User
6.1. Hospital Pharmacy
6.2. Retail Pharmacy
6.3. E-Commerce Websites & Online Drug Stores

7. Geographical Analysis
7.1. North America
7.1.1. The United States
7.1.2. Canada
7.2. Europe
7.2.1. The United Kingdom
7.2.2. France
7.2.3. Germany
7.2.4. Italy
7.2.5. Russia
7.2.6. Belgium
7.2.7. Poland
7.2.8. Rest Of Europe
7.3. Asia Pacific
7.3.1. China
7.3.2. Japan
7.3.3. India
7.3.4. Australia & New Zealand
7.3.5. South Korea
7.3.6. Thailand
7.3.7. Indonesia
7.3.8. Vietnam
7.3.9. Rest Of Asia Pacific
7.4. Rest Of World
7.4.1. Latin America
7.4.2. Middle East & Africa

8. Company Profiles
8.1. Allergan Plc
8.2. Aspire Bariatrics Inc
8.3. Astrazeneca Plc
8.4. Bio-Rad Laboratories Inc
8.5. Boehringer Ingelheim International Gmbh
8.6. Daiichi Sankyo Company Limited
8.7. Hill-Rom Holdings Inc
8.8. Johnson & Johnson
8.9. Lupin Limited
8.10. Medtronic Plc
8.11. Merck & Co Inc
8.12. Novartis Ag
8.13. Pfizer Inc
8.14. Sanofi
8.15. Sun Pharmaceutical Industries Ltd. (Ranbaxy Laboratories)



List of Figures


List of Figures


Figure 1: Number Of Aging Population By Region 2017& 2050 (In Million)
Figure 2: Porter’S Five Force Analysis
Figure 3: Opportunity Matrix
Figure 4: Vendor Landscape
Figure 5: Key Investment Insights
Figure 6: Global Antihypertensive Drugs Market, By Drug Class, In 2019
Figure 7: Global Antihypertensive Drugs Market, By Calcium Channel Blockers, 2019-2028 (In $ Million)
Figure 8: Global Antihypertensive Drugs Market, By Ace Inhibitors, 2019-2028 (In $ Million)
Figure 9: Global Antihypertensive Drugs Market, By Beta-Adrenergic Blockers, 2019-2028 (In $ Million)
Figure 10: Global Antihypertensive Drugs Market, By Diuretics, 2019-2028 (In $ Million)
Figure 11: Global Antihypertensive Drugs Market, By Vasodilators, 2019-2028 (In $ Million)
Figure 12: Global Antihypertensive Drugs Market, By Other Drug Class, 2019-2028 (In $ Million)
Figure 13: Global Antihypertensive Drugs Market, By End-User, In 2019
Figure 14: Global Antihypertensive Drugs Market, By Hospital Pharmacy, 2019-2028 (In $ Million)
Figure 15: Global Antihypertensive Drugs Market, By Retail Pharmacy, 2019-2028 (In $ Million)
Figure 16: Global Antihypertensive Drugs Market, By E-Commerce Websites & Online Drug Stores, 2019-2028 (In $ Million)
Figure 17: North America Antihypertensive Drugs Market, Country Outlook, 2019 & 2028 (In %)
Figure 18: The United States Antihypertensive Drugs Market, 2019-2028 (In $ Million)
Figure 19: Canada Antihypertensive Drugs Market, 2019-2028 (In $ Million)
Figure 20: Europe Antihypertensive Drugs Market, Country Outlook, 2019 & 2028 (In %)
Figure 21: The United Kingdom Antihypertensive Drugs Market, 2019-2028 (In $ Million)
Figure 22: France Antihypertensive Drugs Market, 2019-2028 (In $ Million)
Figure 23: Germany Antihypertensive Drugs Market, 2019-2028 (In $ Million)
Figure 24: Italy Antihypertensive Drugs Market, 2019-2028 (In $ Million)
Figure 25: Russia Antihypertensive Drugs Market, 2019-2028 (In $ Million)
Figure 26: Belgium Antihypertensive Drugs Market, 2019-2028 (In $ Million)
Figure 27: Poland Antihypertensive Drugs Market, 2019-2028 (In $ Million)
Figure 28: Rest Of Europe Antihypertensive Drugs Market, 2019-2028 (In $ Million)
Figure 29: Asia Pacific Antihypertensive Drugs Market, Country Outlook, 2019 & 2028 (In %)
Figure 30: China Antihypertensive Drugs Market, 2019-2028 (In $ Million)
Figure 31: Japan Antihypertensive Drugs Market, 2019-2028 (In $ Million)
Figure 32: India Antihypertensive Drugs Market, 2019-2028 (In $ Million)
Figure 33: Australia & New Zealand Antihypertensive Drugs Market, 2019-2028 (In $ Million)
Figure 34: South Korea Antihypertensive Drugs Market, 2019-2028 (In $ Million)
Figure 35: Thailand Antihypertensive Drugs Market, 2019-2028 (In $ Million)
Figure 36: Indonesia Antihypertensive Drugs Market, 2019-2028 (In $ Million)
Figure 37: Vietnam Antihypertensive Drugs Market, 2019-2028 (In $ Million)
Figure 38: Rest Of Asia Pacific Antihypertensive Drugs Market, 2019-2028 (In $ Million)
Figure 39: Rest Of World Antihypertensive Drugs Market, Regional Outlook, 2019 & 2028 (In %)
Figure 40: Latin America Antihypertensive Drugs Market, 2019-2028 (In $ Million)
Figure 41: Middle East & Africa Antihypertensive Drugs Market, 2019-2028 (In $ Million)

 

List of Tables


List of Tables


TABLE 1: MARKET SNAPSHOT - ANTIHYPERTENSIVE DRUGS
TABLE 2: GLOBAL ANTIHYPERTENSIVE DRUGS MARKET, BY DRUG CLASS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 3: GLOBAL ANTIHYPERTENSIVE DRUGS MARKET, BY DRUG CLASS, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 4: GLOBAL CALCIUM CHANNEL BLOCKERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 5: GLOBAL CALCIUM CHANNEL BLOCKERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 6: GLOBAL ACE INHIBITORS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 7: GLOBAL ACE INHIBITORS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 8: GLOBAL BETA-ADRENERGIC BLOCKERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 9: GLOBAL BETA-ADRENERGIC BLOCKERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 10: GLOBAL DIURETICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 11: GLOBAL DIURETICS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 12: GLOBAL VASODILATORS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 13: GLOBAL VASODILATORS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 14: GLOBAL OTHER DRUG CLASS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 15: GLOBAL OTHER DRUG CLASS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 16: GLOBAL ANTIHYPERTENSIVE DRUGS MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 17: GLOBAL ANTIHYPERTENSIVE DRUGS MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 18: GLOBAL HOSPITAL PHARMACY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 19: GLOBAL HOSPITAL PHARMACY MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 20: GLOBAL RETAIL PHARMACY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 21: GLOBAL RETAIL PHARMACY MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 22: GLOBAL E-COMMERCE WEBSITES & ONLINE DRUG STORES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 23: GLOBAL E-COMMERCE WEBSITES & ONLINE DRUG STORES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 24: GLOBAL ANTIHYPERTENSIVE DRUGS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 25: GLOBAL ANTIHYPERTENSIVE DRUGS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 26: NORTH AMERICA ANTIHYPERTENSIVE DRUGS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 27: NORTH AMERICA ANTIHYPERTENSIVE DRUGS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 28: EUROPE ANTIHYPERTENSIVE DRUGS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 29: EUROPE ANTIHYPERTENSIVE DRUGS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 30: ASIA PACIFIC ANTIHYPERTENSIVE DRUGS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 31: ASIA PACIFIC ANTIHYPERTENSIVE DRUGS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 32: REST OF WORLD ANTIHYPERTENSIVE DRUGS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 33: REST OF WORLD ANTIHYPERTENSIVE DRUGS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)